Reuters logo
in 10 months
BRIEF-ARCA Biopharma announces randomization of first European patients in genetic-AF phase 2b/3 clinical trial
October 6, 2016 / 12:51 PM / in 10 months

BRIEF-ARCA Biopharma announces randomization of first European patients in genetic-AF phase 2b/3 clinical trial

1 Min Read

Oct 6 (Reuters) - ARCA Biopharma Inc :

* Arca Biopharma announces randomization of first European patients in genetic-AF phase 2b/3 clinical trial

* Company expects to randomize at least 150 patients into trial by end of 2016

* Company expects outcome of interim analysis in q2 of 2017

* Genetic-Af DSMB to conduct nterim efficacy, safety,futility analysis of data from at least 150 patients with evaluable data Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below